Safety and effectiveness of TZ-161 for spinal cord injury
Part of Brain & nervous system, Injuries & trauma clinical trials.
This trial tests a new medicine called TZ-161 in people who have recently had a spinal cord injury in the chest area. The goal is to see if it is safe and can help improve movement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- Your spinal cord injury is in the chest area (between T1 and T12) and happened from a single hard hit or bruise.
- Your injury is rated AIS B, C, or D, and you have limited movement in at least one leg muscle.
- You can receive the study drug within 24 hours of your injury.
- You are willing and able to give consent and follow the study rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a mild electrical stimulation (called TENS) can help recovery after a recent spinal cord injury. It is for people who are already in the ICU with a drain in their lower back and had a blunt injury within the past 12 hours.
This study tests a new medicine called KP-100IT for people who have a severe spinal cord injury (AIS grade A) with no function below the injury level. The goal is to see if the medicine can help improve recovery.
This Phase 2 trial tests sotateltide (PMZ-1620) in people with a recent spinal cord injury. It aims to see whether the drug can improve neurological recovery after injury, especially in certain levels and types of incomplete injuries.
This trial tests whether an implanted device that sends electrical pulses to the spinal cord can help people with spinal cord injuries regain movement. It is for those who have not seen recent improvement with rehab.
This trial tests a treatment to help people with chronic spinal cord injury improve arm and hand function. It combines two therapies to see if they work better together.
This trial tests whether epidural electrical stimulation can help people with spinal cord injury between T11 and L3 improve their walking ability. It is for those injured between 2 and 24 months ago who currently have limited walking function.
Hear when a new Acute Spinal Cord Injury (SCI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.